TELA Bio to Participate in Upcoming Investor Conferences
August 05, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting
August 04, 2022 07:00 ET
|
TELA Bio, Inc.
24-Month BRAVO study results showed a 2.6% recurrence rate in diverse clinical scenarios Robotic Reinforced Biologic Augmented Repair (ReBAR) study showed a 1.9% recurrence rate at two-year mark ...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 29, 2022 16:01 ET
|
TELA Bio, Inc.
MALVERN, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Announce Second Quarter 2022 Financial Results
July 27, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.
July 20, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., July 20, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
June 02, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., June 02, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial
May 31, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Participate in Upcoming Jefferies Healthcare Conference
May 26, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Reports First Quarter 2022 Financial Results
May 10, 2022 16:01 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conference
May 09, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...